Article (Scientific journals)
Cost-consequences analysis of increased utilization of triple-chamber-bag parenteral nutrition in preterm neonates in seven European countries
Kriz, A.; Wright, A.; Paulsson, M. et al.
2020In Nutrients, 12 (9), p. 1-17
Peer Reviewed verified by ORBi
 

Files


Full Text
nutrients-12-02531-v2.pdf
Publisher postprint (317.93 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Compounding errors; Cost-consequence analysis; Parenteral nutrition; Preterm neonates; Ready-to-use three-chamber-bags
Abstract :
[en] The safety of parenteral nutrition (PN) remains a concern in preterm neonates, impacting clinical outcomes and health-care-resource use and costs. This cost-consequence analysis assessed national-level impacts of a 10-percentage point increase in use of industry-prepared three-chamber bags (3CBs) on clinical outcomes, healthcare resources, and hospital budgets across seven European countries. A ten-percentage-point 3CB use-increase model was developed for Belgium, France, Germany, Italy, Portugal, Spain, and the UK. The cost-consequence analysis estimated the impact on compounding error harm and bloodstream infection (BSI) rates, staff time, and annual hospital budget. Of 265,000 (52%) preterm neonates, 133,000 (52%) were estimated to require PN. Baseline compounding methods were estimated as 43% pharmacy manual, 16% pharmacy automated, 22% ward, 9% outsourced, 3% industry provided non-3CBs, and 7% 3CBs. A modeled increased 3CB use would change these values to 39%, 15%, 18%, 9%, 3%, and 17%, respectively. Modeled consequences included −11.6% for harm due to compounding errors and −2.7% for BSIs. Labor time saved would equate to 41 specialized nurses, 29 senior pharmacists, 26 pharmacy assistants, and 22 senior pediatricians working full time. Budget impact would be a €8,960,601 (3.4%) fall from €260,329,814 to €251,369,212. Even a small increase in the use of 3CBs in preterm neonates could substantially improve neonatal clinical outcomes, and provide notable resource and cost savings to hospitals. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Disciplines :
Pediatrics
Author, co-author :
Kriz, A.;  Executive Insight AG, Zurich, 8008, Switzerland
Wright, A.;  Maverex Ltd., Newcastle upon Tyne, NE6 2HL, United Kingdom
Paulsson, M.;  Department of Women’s and Children’s Health, Uppsala University, Uppsala, 751 85, Sweden
Tomlin, S.;  Great Ormond Street Hospital, London, WC1N 3JH, United Kingdom
Simchowitz, V.;  Great Ormond Street Hospital, London, WC1N 3JH, United Kingdom
Senterre, Thibault ;  Université de Liège - ULiège > Département des sciences de la santé publique > Département des sciences de la santé publique
Shepelev, J.;  Baxter Healthcare Ltd., Compton, RG20 7QW, United Kingdom
Language :
English
Title :
Cost-consequences analysis of increased utilization of triple-chamber-bag parenteral nutrition in preterm neonates in seven European countries
Publication date :
2020
Journal title :
Nutrients
ISSN :
2072-6643
Publisher :
MDPI AG
Volume :
12
Issue :
9
Pages :
1-17
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
Baxter Healthcare Corporation
Available on ORBi :
since 31 August 2020

Statistics


Number of views
41 (4 by ULiège)
Number of downloads
1 (1 by ULiège)

Scopus citations®
 
4
Scopus citations®
without self-citations
4
OpenCitations
 
0

Bibliography


Similar publications



Contact ORBi